Market Update: Actavis plc (NYSE:ACT) – Actavis Confirms Appeals Court Upholds Lo Loestrin® Fe Patent
October 23, 2014 at 08:00 AM EDT
[PR Newswire] – DUBLIN, Oct. 23, 2014 /PRNewswire/ — Actavis plc (ACT) today confirmed that the United States Court of Appeals for the Federal Circuit has upheld a lower court ruling that found . . . → Read More: Market Update: Actavis plc (NYSE:ACT) – Actavis Confirms Appeals Court Upholds Lo Loestrin® Fe Patent Similar Articles: Market Update (NYSE:ACT): Actavis to Acquire Durata Therapeutics, Inc. Stock Update: Actavis plc (NYSE:ACT) – Actavis Confirms Generic Butrans® Patent Challenge Company Update (NYSE:ACT): Actavis to Present at Morgan Stanley Global Healthcare Conference 2014
